Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
131
days
RASD 2 Drives Renal Clear Cell Carcinoma Progression via RAF 1 (Ser338) Phosphorylation
AuthorsJingxuan Yu; Gang Yu; Yuan Liu; Yu Zhou; Wei Liu; Lin Wang; Lide Liu; Yan Liu; Tiejun Pan; Zhenyu Liu; Lei Gao
Affiliations1. Department of Urology, Postgraduate Union Training Base of General Hospital of Central Theater Command, School of Medicine Wuhan University of Science and Technology Wuhan Hubei China; 2. Department of Urology General Hospital of Central Theater Command of Chinese People's Liberation Army Wuhan Hubei China; 3. Xianning Central Hospital The First Affiliated Hospital of Hubei University of Science and Technology Xianning Hubei China; 4. Southwest Hospital, Army Medical University (Third Military Medical University) Chongqing China; 5. General Hospital of Central Theater Command and Hubei Key Laboratory of Central Nervous System Tumor and Intervention Wuhan Hubei China; 6. School of Clinical Medicine Hubei University of Chinese Medicine Wuhan Hubei China
95
days
Afatinib Versus Osimertinib for Non‐Small Cell Lung Cancer With Uncommon EGFR Mutations: Real‐World Outcomes
AuthorsYutaro Nagano; Hiroshi Yokouchi; Ryota Saito; Osamu Honjo; Toshiyuki Sumi; Takayuki Kaburagi; Kenichiro Ito; Yasuyuki Ikezawa; Keiki Yokoo; Hajime Kikuchi; Sayaka Kudo; Masami Yamazoe; Ryota Shigaki; Keita Tagami; Toshiyuki Tenma; Tatsuru Ishikawa; Mamoru Takahashi; Takaaki Sasaki; Hajime Asahina; Shiro Hinotsu; Hirofumi Chiba; Satoshi Oizumi
Affiliations1. Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine Sapporo Japan; 2. Department of Respiratory Medicine NHO Hokkaido Cancer Center Sapporo Japan; 3. Department of Respiratory Medicine Yamanashi Prefectural Central Hospital Yamanashi Japan; 4. Department of Respiratory Medicine Sapporo Minami‐Sanjo Hospital Sapporo Japan; 5. Department of Respiratory Medicine Hakodate Goryoukaku Hospital Hakodate Japan; 6. Department of Respiratory Medicine Ibaraki Prefectural Central Hospital Kasama Japan; 7. Department of Respiratory Medicine KKR Sapporo Medical Center Sapporo Japan; 8. Department of Respiratory Medicine Hokkaido University Hospital Sapporo Japan; 9. Department of Respiratory Medicine Teine Keijinkai Hospital Sapporo Japan; 10. Department of Respiratory Medicine Obihiro Kosei Hospital Obihiro Japan; 11. Department of Respiratory Medicine Kushiro City General Hospital Kushiro Japan; 12. Department of Respiratory Medicine Hakodate Municipal Hospital Hakodate Japan; 13. Department of Respiratory Medicine Hokkaido Prefectural Kitami Hospital Kitami Japan; 14. Department of Respiratory Medicine Nayoro City General Hospital Nayoro Japan; 15. Department of Internal Medicine, Division of Respiratory Medicine and Neurology Asahikawa Medical University Asahikawa Japan; 16. Department of Biostatistics and Data Management Sapporo Medical University School of Medicine Sapporo Japan
50
days
Interpreting Early‐Onset Colorectal Cancer in Japan: A Descriptive Epidemiologic Review Using Public Summary Statistics
AuthorsKeitaro Matsuo; Hidemi Ito
Affiliations1. Division of Cancer Epidemiology and Prevention Aichi Cancer Center Nagoya Aichi Japan; 2. Division of Cancer Epidemiology Nagoya University Graduate School of Medicine Nagoya Aichi Japan; 3. Division of Cancer Information and Control Aichi Cancer Center Nagoya Aichi Japan; 4. Division of Descriptive Cancer Epidemiology Nagoya University Graduate School of Medicine Nagoya Aichi Japan
149
days
Gasdermin‐Mediated Pyroptosis: Novel Strategies Against Colorectal Cancer
AuthorsKaibo Guo; Yuqian Feng; Jiamin Lu; Nuerbiye Abudurexiti; Xinlei Zhou; Mengfan Wei; Song Zheng
Affiliations1. Department of Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine Westlake University Hangzhou China; 2. Key Laboratory of Clinical Cancer Pharmacology & Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine Westlake University Hangzhou China; 3. Department of Geriatrics The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine) Hangzhou China; 4. Department of Oncology The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine) Hangzhou China; 5. Department of Oncology, the Fourth School of Clinical Medicine Zhejiang Chinese Medical University Hangzhou China; 6. The Third Clinical Medical School, the Rehabilitation Medical School Zhejiang Chinese Medical University Hangzhou China; 7. School of Medical Technology and Information Engineering Zhejiang Chinese Medical University Hangzhou China
64
days
Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights
AuthorsToru Odate; Tetsuo Kondo
Affiliations1. Department of Pathology University of Yamanashi Yamanashi Japan
145
days
First‐In‐Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck
AuthorsNobuaki Matsubara; Ken Saijo; Yasushi Shimizu; Susumu Okano; Kenji Nakano; Naoki Nishio; Tomoyuki Otsuka; Hirofumi Kuno; Takuma Miura; Tomoki Kubota; Hiroki Ikezawa; Yuko Umetsu; Ken Ito; Abraham Apfel; Yuanqing Ye; Yoshitaka Honma
Affiliations1. Department of Medical Oncology National Cancer Center Hospital East Kashiwa Chiba Japan; 2. Department of Medical Oncology Tohoku University Hospital Sendai Japan; 3. Department of Medical Oncology Hokkaido University Hospital Sapporo Hokkaido Japan; 4. Department of Head and Neck Medical Oncology National Cancer Center Hospital East Kashiwa Chiba Japan; 5. Department of Medical Oncology Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan; 6. Department of Otorhinolaryngology Nagoya University Hospital Nagoya Japan; 7. Department of Medical Oncology Osaka International Cancer Institute Osaka Japan; 8. Department of Diagnostic Radiology National Cancer Center Hospital East Kashiwa Chiba Japan; 9. Japan and Asia Clinical Development Department Eisai Co. Ltd. Tokyo Japan; 10. Clinical Data Science Department Eisai Co. Ltd. Tokyo Japan; 11. Clinical Pharmacology & Translational Research Department Eisai Co. Ltd. Tokyo Japan; 12. Oncology Discovery Department Eisai Co. Ltd. Ibaraki Japan; 13. Clinical Data Science Eisai Inc. Nutley New Jersey USA; 14. Department of Head and Neck, Esophageal Medical Oncology National Cancer Center Hospital Tokyo Japan
46
days
MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal Therapy
AuthorsHiroaki Ikushima; Hidenori Kage
Affiliations1. Department of Respiratory Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan
43
days
Pathophysiological and Molecular Features of DXd ADC ‐Related Interstitial Pneumonitis in Cynomolgus Monkeys
AuthorsKazuyoshi Kumagai; Takuma Iguchi; Kentaro Kubota; Ken Sakurai; Yoshimi Tsuchiya; Katsuyoshi Chiba
Affiliations1. Medicinal Safety Research Laboratories Daiichi Sankyo Co., Ltd. Tokyo Japan; 2. Medicinal Safety Daiichi Sankyo Inc. Basking Ridge New Jersey USA
149
days
Epithelial YPEL3 Modulates CD8 + T‐Cell Infiltration and Tumor Progression Through CREB1–CXCL16 Signaling in HNSCC
AuthorsYalun Li; Yumei Li; Caiyu Sun; Congxian Lu; Gang Chen; Tianshu Zhou; Bei Zhang; Xicheng Song
Affiliations1. Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital Qingdao University Yantai China; 2. Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation Yantai China; 3. Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases Yantai China; 4. Yantai Key Laboratory of Otorhinolaryngologic Diseases Yantai China; 5. School of Basic Medicine Qingdao University Yantai China; 6. Department of Breast Surgery, Yantai Yuhuangding Hospital Qingdao University Yantai China
99
days
Tumor‐Derived Extracellular Vesicles in Plasma for Predicting Anti‐ PD ‐1 Antibody Efficacy in Non‐Small Cell Lung Cancer
AuthorsTomonari Kinoshita; Shigeki Ohta; Seiki Wakui; Chihaya Maeda; Yuichiro Hayashi; Aya Misawa; Ryosuke Satomi; Shinnosuke Ikemura; Kenzo Soejima; Tomonori Yaguchi; Shotaro Maruyama; Hiroshi Kagamu; Yutaka Kawakami
Affiliations1. Division of General Thoracic Surgery, Department of Surgery Keio University School of Medicine Tokyo Japan; 2. Division of Cellular Signaling, Institute for Advanced Medical Research Keio University School of Medicine Tokyo Japan; 3. Department of Immunology, School of Medicine International University of Health and Welfare Chiba Japan; 4. JSR‐Keio University Medical and Chemical Innovation Center (JKiC) Tokyo Japan; 5. Division of Pathology Keio University School of Medicine Tokyo Japan; 6. Department of Pathology International University of Health and Welfare, Narita Hospital Chiba Japan; 7. Department of Pulmonary Medicine National Hospital, Organization, Tokyo Medical Center Tokyo Japan; 8. Department of Pulmonary Medicine Keio University School of Medicine Tokyo Japan; 9. Department of Respiratory Medicine, Comprehensive Cancer Center International Medical Center, Saitama Medical University Saitama Japan
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days